How many institutions held SXTC - China SXT Pharmaceuticals, Inc. - Common stock, $0.08 par value in Q1 2024?

3 institutional investors reported SXTC - China SXT Pharmaceuticals, Inc. - Common stock, $0.08 par value for Q1 2024. Use the holders table for investor-level position and value details.

China SXT Pharmaceuticals, Inc. - Common stock, $0.08 par value (SXTC)

Q: What does CUSIP G2161P140 represent in this 13F holders report?

CUSIP G2161P140 is the security identifier for SXTC - China SXT Pharmaceuticals, Inc. - Common stock, $0.08 par value used to aggregate holder disclosures.

CUSIP: G2161P140

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class: Equity / Common stock, $0.08 par value
Total 13F shares: 2,870
Share change: -6,300
Total reported value: $3,186
Price per share: $1.62
Number of holders: 3
Value change: -$10,232
Number of buys: 1
Number of sells: 1

Quarterly Holders Quick Answers

What is CUSIP G2161P140?
CUSIP G2161P140 identifies SXTC - China SXT Pharmaceuticals, Inc. - Common stock, $0.08 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2024
Previous quarter: Q4 2023

Recent filing periods for CUSIP G2161P140:

Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023

Top shareholders of SXTC - China SXT Pharmaceuticals, Inc. - Common stock, $0.08 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Marex Group plc	13F	Company	— class O/S missing	41,293	$163,933	—	31 Dec 2023	13F
UBS Group AG	13F	Company	— class O/S missing	6,408	$25,440	—	31 Dec 2023	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	— class O/S missing	2,759	$10,000	—	31 Dec 2023	13F
Qube Research & Technologies Ltd	13F	Company	— class O/S missing	3	$12	—	31 Dec 2023	13F

Institutional Holders of China SXT Pharmaceuticals, Inc. - Common stock, $0.08 par value (SXTC) as of Q1 2024

As of 31 Mar 2024, China SXT Pharmaceuticals, Inc. - Common stock, $0.08 par value (SXTC) was held by 3 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,870 shares. The largest 3 holders included ACADIAN ASSET MANAGEMENT LLC, Qube Research & Technologies Ltd, and UBS Group AG. This page lists 3 institutional shareholders reporting positions in this security for the Q1 2024 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2024 vs Q4 2023 Across Filers

Q4 2023 holders

Q1 2024 holders

Holder diff

Investor	Q4 2023 Shares	Q1 2024 Shares	Share Diff	Share Chg %	Q4 2023 Value $	Q1 2024 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.